Q32 Bio Inc. vs Tridek-One
Q32 Bio Inc.
Revolutionizing the future of targeted immune therapeutics
28 employees · est. 2017 · Waltham, United States
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases
12 employees · est. 2018 · Paris, France
Q32 Bio Inc. is the older company (2017 vs 2018).
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Q32 Bio Inc. | Tridek-One |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2018 |
| Headquarters | ||
| Headquarters | Waltham, United States | Paris, France |
| Employees | ||
| Employees | 28 | 12 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Venture round |
| Total Funding | ||
| Total Funding | $255.50M | $19.00M |
| Funding Rounds | ||
| Funding Rounds | 7 | 2 |
| Services | ||
| Services | Not tracked yet | Development of first-in-class CD31 checkpoint agonists for the treatment of autoimmune and inflammatory diseases. |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with autoimmune and inflammatory diseases, healthcare providers, pharmaceutical companies, and biotech research institutions. |
| Taxonomy | ||
| Taxonomy | Immune TherapeuticsIL-7 PathwayComplement SystemAutoimmune DiseasesInflammatory DiseasesImmunotherapy +8 | ImmunomodulationTherapeutic AntibodiesAutoimmune DiseasesInflammatory DisordersBiopharmaceuticalsImmunotherapy +8 |
| Website | ||
| Website | q32bio.com | tridekone.com |
About Q32 Bio Inc.
Q32 Bio Inc. is a leading biotechnology company with a mission to revolutionize the future of targeted immune therapeutics. Established in 2017, the company is headquartered in the United States. Q32 Bio is dedicated to developing innovative therapeutics that target powerful regulators of the innate...
About Tridek-One
Tridek-One is a French biotechnology startup founded in 2018, specializing in the development of first-in-class therapeutic agonistic monoclonal antibodies targeting immune checkpoint inhibitory receptors for the treatment of autoimmune and inflammatory diseases. The company's focus on anti-CD31 ago...
Also comparing in this category
Comparing more than these two?
Get Q32 Bio Inc., Tridek-One and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Q32 Bio Inc. compare?
A PDF of Q32 Bio Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Q32 Bio Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Q32 Bio Inc. on 9 Jun 2026, and Tridek-One on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
